InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: jessellivermore post# 9286

Wednesday, 06/26/2013 8:09:00 AM

Wednesday, June 26, 2013 8:09:00 AM

Post# of 426735
I think there could have been a BO last year with a quick NCE decision, however once they had to launch Marine I didn't see any reason for a BO until 6 months to a year into Anchor as it makes no sense to sell before Anchor is launched. Slight possibility of a BO if NCE is positive and Anchor Adcom clearly shows Anchor will be approved but odds are very high there will be a partnership for Anchor launch-which WS will likely love as they hate the small bio GIA look. I believe that partner will then buy the company 6 months to a year into Anchor launch. I've been thinking that will be the way it plays out since they had to launch marine.

Having a full year in marine and moving towards Tier 2 gives Anchor launch a giant head start. Add to that the large Lovaza off label useage and the ramp up for Anchor with the proper sales force will be enormous-much bigger than if they did not have marine to start.
They should have a full year to get Tier 2 so by Anchor launch expect large tier 2 coverage, a sales force north of 1,000, an experienced partner, much cheaper than Lovaza with insurance coverage for Anchor...that is the ideal..that is why I hold the stock through the initial launch downturn and look towards Anchor.

BO is still the end goal but agree it's not happening until mid-2014 at the earliest.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News